DriveWealth has been valued at $2.85bn in a series D round featuring Softbank Vision Fund 2, Citi Ventures and FTX.
Month: August 2021
QuintoAndar lists another $120m
With backing from Tencent, the online real estate platform has pushed its series E round to $420m.
ThoughtWorks imagines public listing
Siemens-backed software consultancy ThoughtWorks has announced its intention to float on the Nasdaq Global Select Market.
iCims files for $100m IPO
SIG could exit recruitment software developer iCims through an initial public offering later this year.
Metanet Tplatform uplinks with $100m investment
Metanet’s cloud integration subsidiary is getting a $100m boost to accelerate its offerings and expand its footprint.
JustCo gets $74m injection
The co-working space provider secured additional capital from Daito Trust to further expand across Asia Pacific.
MobileCoin ledgers $66m series B
Cryptocurrency exchange Coinbase’s corporate venturing arm is among the investors set to boost the payment platform’s expansion.
Analysis: First-time corporate investors
Over the past few years, roughly a fifth to a quarter of all corporate investors whose deals we track appear to be newcomers.
Daily Deal Round Up: August 20, 2021
M12 backed three deals in recent days, including a $50m series D round for Split.io that also featured fellow corporates Atlassian and ServiceNow.
NewLink zaps on $308m
The Nio and Xiaomi-backed EV charging platform has added another tranche to its series E round, bringing it to $608m.
Apollo GraphQL inputs $130m
Apollo has been valued at over $1.5bn after raising funding from investors including Siemens’ Next47 unit.
Shukun Technology pumps in $108m
ThunderSoft-backed Shukun Technology has revealed fresh funding as it looks to develop its AI technology.
Fontinalis wraps up $104m fund
With backing from Ford and unnamed corporates, the mobility-focused venture capital firm has closed its third investment vehicle.
Vigil scoops up $90m in series B
The Amgen-backed neurodegenerative disease treatment specialist is set to fund new medical studies.